{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:24:39Z","timestamp":1774779879170,"version":"3.50.1"},"reference-count":10,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.3899\/jrheum.181051","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:16:58Z","timestamp":1563193018000},"page":"1250-1251","source":"Crossref","is-referenced-by-count":4,"title":["Febuxostat Desensitization in a Patient with Previous Stevens-Johnson Syndrome and <i>HLA-B*58:01<\/i> Genotype"],"prefix":"10.3899","volume":"46","author":[{"given":"TENNEILLE","family":"TANA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PETER","family":"VADAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"2019090109250716000_46.9.1250.1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpt.161","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update","volume":"99","author":"Saito","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"2019090109250716000_46.9.1250.2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/1756-185X.13143","article-title":"Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis","volume":"20","author":"Yu","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2019090109250716000_46.9.1250.3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21772"},{"key":"2019090109250716000_46.9.1250.4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.semarthrit.2016.10.009","article-title":"The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States","volume":"46","author":"Jutkowitz","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2019090109250716000_46.9.1250.5","unstructured":"US Food and Drug Administration . Table of pharmacogenomic biomarkers in drug labeling. December 2018. [Internet. Accessed April 15, 2019.] Available from: www.fda.gov\/downloads\/Drugs\/ScienceResearch\/UCM578588.pdf"},{"key":"2019090109250716000_46.9.1250.6","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.amjmed.2016.08.042","article-title":"Cross-reactions between allopurinol and febuxostat","volume":"130","author":"Lien","year":"2017","journal-title":"Am J Med"},{"key":"2019090109250716000_46.9.1250.7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/03009742.2015.1099729","article-title":"Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study","volume":"45","author":"Yu","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"2019090109250716000_46.9.1250.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110092"},{"key":"2019090109250716000_46.9.1250.9","first-page":"1","article-title":"Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: a Malaysian experience","volume":"5","author":"Sulaiman","year":"2017","journal-title":"SAGE Open Med Case Report"},{"key":"2019090109250716000_46.9.1250.10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2015.01.022","article-title":"Desensitization to febuxostat: report of two cases","volume":"3","author":"Di Paolo","year":"2015","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T12:25:57Z","timestamp":1567340757000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,1]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.3899\/jrheum.181051"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181051","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}